{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:43:21Z","timestamp":1780760601262,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009873","name":"Regione Autonoma della Sardegna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["SSMF 30072019"],"award-info":[{"award-number":["SSMF 30072019"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-01066"],"award-info":[{"award-number":["2019-01066"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-935235"],"award-info":[{"award-number":["SLS-935235"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112234","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T18:54:58Z","timestamp":1633028098000},"page":"112234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank"],"prefix":"10.1016","volume":"143","author":[{"given":"Claudia","family":"Pisanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike Zoe","family":"Welander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gull","family":"Rukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi Birgir","family":"Schi\u00f6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mwinyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.112234_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-198632010-00002","article-title":"Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome","volume":"32","author":"Clissold","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2021.112234_bib2","first-page":"477","article-title":"The indications, applications, and risks of proton pump inhibitors","volume":"113","author":"Mossner","year":"2016","journal-title":"Dtsch. Arzteblatt Int."},{"issue":"4","key":"10.1016\/j.biopha.2021.112234_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00002018-200225040-00005","article-title":"Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study","volume":"25","author":"Claessens","year":"2002","journal-title":"Drug Saf."},{"issue":"10100","key":"10.1016\/j.biopha.2021.112234_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Disease","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2021.112234_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0333102419884935","article-title":"Major depression subtypes are differentially associated with migraine subtype, prevalence and severity","volume":"40","author":"Pisanu","year":"2020","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.biopha.2021.112234_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00127-019-01755-1","article-title":"Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016","volume":"55","author":"Jeyagurunathan","year":"2020","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.biopha.2021.112234_bib7","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","article-title":"Migraine: integrated approaches to clinical management and emerging treatments","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.112234_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","article-title":"Migraine: disease characterisation, biomarkers, and precision medicine","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.112234_bib9","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition, Cephalalgia 38(1),\u00a02018, 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"10.1016\/j.biopha.2021.112234_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15657","article-title":"Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments","author":"Zobdeh","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112234_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neurol.2021.07.006","article-title":"Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: pharmacological treatment","volume":"177","author":"Ducros","year":"2021","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.biopha.2021.112234_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neurol.2021.07.009","article-title":"Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: non-pharmacological treatment","volume":"177","author":"Demarquay","year":"2021","journal-title":"Rev. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112234_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00439-017-1816-5","article-title":"A genetic risk score is differentially associated with migraine with and without aura","volume":"136","author":"Pisanu","year":"2017","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2021.112234_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0333102414535114","article-title":"Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan","volume":"35","author":"Liang","year":"2015","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.biopha.2021.112234_bib15","doi-asserted-by":"crossref","first-page":"17280","DOI":"10.1038\/s41598-019-53622-3","article-title":"Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory","volume":"9","author":"Makunts","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112234_bib16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2021.112234_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"El Rouby","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112234_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2008.01.002","article-title":"Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450","volume":"471","author":"Fer","year":"2008","journal-title":"Arch. Biochem Biophys."},{"issue":"3","key":"10.1016\/j.biopha.2021.112234_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1055-9965.EPI-05-0801","article-title":"Role of polymorphic human cytochrome P450 enzymes in estrone oxidation","volume":"15","author":"Cribb","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"8","key":"10.1016\/j.biopha.2021.112234_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.psyneuen.2011.05.004","article-title":"Sex steroids and connectivity in the human brain: a review of neuroimaging studies","volume":"36","author":"Peper","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2021.112234_bib21","first-page":"2","article-title":"Pharmacogenomics of cytochrome P450 dependent metabolism of endogenous compounds: implications for behavior,\u00a0psychopathology and treatment","volume":"5","author":"Persson","year":"2014","journal-title":"J. Pharm. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2021.112234_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/joim.12317","article-title":"Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs","volume":"277","author":"Stingl","year":"2015","journal-title":"J. Intern Med"},{"key":"10.1016\/j.biopha.2021.112234_bib23","doi-asserted-by":"crossref","unstructured":"J.C. Stingl, C. Scholl, J.E. Bosch, R.\u00a0Viviani, Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain, 2020, 2020.12.18.423183.","DOI":"10.1101\/2020.12.18.423183"},{"issue":"6","key":"10.1016\/j.biopha.2021.112234_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/mp.2013.89","article-title":"Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene","volume":"19","author":"Persson","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2021.112234_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/mp.2017.93","article-title":"Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment","volume":"22","author":"Jukic","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2021.112234_bib26","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ajmg.b.31081","article-title":"Association between CYP2C19 polymorphism and depressive symptoms","volume":"153B","author":"Sim","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.biopha.2021.112234_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112984","article-title":"Impact of CYP2C19 genotype-predicted enzyme activity on hippocampal volume, anxiety, and depression","volume":"288","author":"Savadlou","year":"2020","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.biopha.2021.112234_bib28","doi-asserted-by":"crossref","first-page":"1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"issue":"7726","key":"10.1016\/j.biopha.2021.112234_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112234_bib30","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/brb3.2291","article-title":"Migraine and gastrointestinal disorders in middle and old age: a UK Biobank study","volume":"11","author":"Welander","year":"2021","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.biopha.2021.112234_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","article-title":"Advance in genetics of migraine","volume":"32","author":"de Boer","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112234_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.17772\/gp\/2002","article-title":"Gender-specific implications for pharmacology in childbearing age and in postmenopausal women","volume":"86","author":"Bartkowiak-Wieczorek","year":"2015","journal-title":"Ginekol. Pol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112234_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How important are gender differences in pharmacokinetics?","volume":"41","author":"Meibohm","year":"2002","journal-title":"Clin. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2021.112234_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2125.2000.00262.x","article-title":"The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies","volume":"50","author":"Martin","year":"2000","journal-title":"Br. J. Clin. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:56:56Z","timestamp":1771919816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221010180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"alternative-id":["S0753332221010180"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112234","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112234"}}